Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1AMR
|
||||
Drug Name |
N-((4-(4-cyanobenzyl)-4H-1,2,4-triazol-3-yl)methyl)-N-(4-nitrobenzyl)quinoline-2-carboxamide
|
||||
Synonyms |
CHEMBL200291
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H21N7O3
|
||||
Canonical SMILES |
[O-][N+](=O)c1ccc(CN(Cc2nncn2Cc3ccc(cc3)C#N)C(=O)c4ccc5ccccc5n4)cc1
|
||||
InChI |
InChI=1S/C28H21N7O3/c29-15-20-5-7-21(8-6-20)17-34-19-30-32-27(34)18-33(16-22-9-12-24(13-10-22)35(37)38)28(36)26-14-11-23-3-1-2-4-25(23)31-26/h1-14,19H,16-18H2
|
||||
InChIKey |
XJVUCSNFEJKWBV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.